187 related articles for article (PubMed ID: 1535679)
1. Diazoxide infusion at excess but not at basal hyperglycemia enhances beta-cell sensitivity to glucose in vitro in neonatally streptozotocin-diabetic rats.
Sako Y; Grill VE
Metabolism; 1992 Jul; 41(7):738-43. PubMed ID: 1535679
[TBL] [Abstract][Full Text] [Related]
2. Impact of uncoupling glucose stimulus from secretion on B-cell release and biosynthesis.
Sako Y; Eizirik D; Grill V
Am J Physiol; 1992 Feb; 262(2 Pt 1):E150-4. PubMed ID: 1539640
[TBL] [Abstract][Full Text] [Related]
3. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
Portha B; Serradas P
Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
[TBL] [Abstract][Full Text] [Related]
4. Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats.
Leahy JL; Bumbalo LM; Chen C
Diabetes; 1994 Feb; 43(2):173-9. PubMed ID: 8288040
[TBL] [Abstract][Full Text] [Related]
5. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
Serradas P; Bailbé D; Portha B
Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
[TBL] [Abstract][Full Text] [Related]
6. Coupling of beta-cell desensitization by hyperglycemia to excessive stimulation and circulating insulin in glucose-infused rats.
Sako Y; Grill VE
Diabetes; 1990 Dec; 39(12):1580-3. PubMed ID: 2245882
[TBL] [Abstract][Full Text] [Related]
7. Treatment with diazoxide causes prolonged improvement of beta-cell function in rat islets transplanted to a diabetic environment.
Hiramatsu S; Höög A; Möller C; Grill V
Metabolism; 2000 May; 49(5):657-61. PubMed ID: 10831179
[TBL] [Abstract][Full Text] [Related]
8. Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats: a defect ameliorated by cAMP.
Abdel-Halim SM; Guenifi A; Khan A; Larsson O; Berggren PO; Ostenson CG; Efendić S
Diabetes; 1996 Jul; 45(7):934-40. PubMed ID: 8666145
[TBL] [Abstract][Full Text] [Related]
9. Multiple abnormalities in insulin responses to nonglucose nutrients in neonatally streptozotocin diabetic rats.
Grill V; Sako Y; Ostenson CG; Jalkanen P
Endocrinology; 1991 Apr; 128(4):2195-203. PubMed ID: 1706269
[TBL] [Abstract][Full Text] [Related]
10. Effects of diazoxide on alpha- and beta-cell function in isolated perfused rat pancreas.
Hirose H; Maruyama H; Ito K; Kido K; Koyama K; Saruta T
Diabetes Res Clin Pract; 1994 Sep; 25(2):77-82. PubMed ID: 7821194
[TBL] [Abstract][Full Text] [Related]
11. Glucagon, insulin and somatostatin secretion in response to sympathetic neural activation in streptozotocin-induced diabetic rats. A study with the isolated perfused rat pancreas in vitro.
Kurose T; Tsuda K; Ishida H; Tsuji K; Okamoto Y; Tsuura Y; Kato S; Usami M; Imura H; Seino Y
Diabetologia; 1992 Nov; 35(11):1035-41. PubMed ID: 1361917
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities of insulin responses after ambient and previous exposure to glucose in streptozocin-diabetic and dexamethasone-treated rats. Role of hyperglycemia and increased B-cell demands.
Grill V; Rundfeldt M
Diabetes; 1986 Jan; 35(1):44-51. PubMed ID: 2416619
[TBL] [Abstract][Full Text] [Related]
13. B-cell insensitivity in vitro: reversal by diazoxide entails more than one event in stimulus-secretion coupling.
Björklund A; Grill V
Endocrinology; 1993 Mar; 132(3):1319-28. PubMed ID: 7679978
[TBL] [Abstract][Full Text] [Related]
14. Abnormal B-cell function in rats with non-insulin-dependent diabetes induced by neonatal streptozotocin: effect of in vivo insulin, phlorizin, or vanadate treatments.
Serradas P; Bailbé D; Blondel O; Portha B
Pancreas; 1991 Jan; 6(1):54-62. PubMed ID: 1994380
[TBL] [Abstract][Full Text] [Related]
15. Defective stimulus-secretion coupling in islets of Psammomys obesus, an animal model for type 2 diabetes.
Nesher R; Warwar N; Khan A; Efendic S; Cerasi E; Kaiser N
Diabetes; 2001 Feb; 50(2):308-14. PubMed ID: 11272141
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro increased pancreatic beta-cell sensitivity to glucose in normal rats submitted to a 48-h hyperglycaemic period.
Thibault C; Guettet C; Laury MC; N'Guyen JM; Tormo MA; Bailbé D; Portha B; Pénicaud L; Ktorza A
Diabetologia; 1993 Jul; 36(7):589-95. PubMed ID: 8359576
[TBL] [Abstract][Full Text] [Related]
17. K(ATP) channel openers protect rat islets against the toxic effect of streptozotocin.
Kullin M; Li Z; Hansen JB; Björk E; Sandler S; Karlsson FA
Diabetes; 2000 Jul; 49(7):1131-6. PubMed ID: 10909969
[TBL] [Abstract][Full Text] [Related]
18. Irreversible loss of normal beta-cell regulation by glucose in neonatally streptozotocin diabetic rats.
Inoue K; Cetkovic-Cvrlje M; Eizirik DL; Grill V
Diabetologia; 1994 Apr; 37(4):351-7. PubMed ID: 8063034
[TBL] [Abstract][Full Text] [Related]
19. Rescue of beta-cell exhaustion by diazoxide after the development of diabetes mellitus in rats with streptozotocin-induced diabetes.
Matsuda M; Kawasaki F; Mikami Y; Takeuchi Y; Saito M; Eto M; Kaku K
Eur J Pharmacol; 2002 Oct; 453(1):141-8. PubMed ID: 12393069
[TBL] [Abstract][Full Text] [Related]
20. Basal insulin hypersecretion in insulin-resistant Zucker diabetic and Zucker fatty rats: role of enhanced fuel metabolism.
Zhou YP; Cockburn BN; Pugh W; Polonsky KS
Metabolism; 1999 Jul; 48(7):857-64. PubMed ID: 10421226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
